Leadership

The Morgridge Institute for Research is led by Interim Executive Director James Dahlberg and governed by a board of trustees. As an independent, private, 501(c)3 Medical Research Organization, the leadership of the institute is committed to a strategic alliance with the Wisconsin Institute for Discovery, the University of Wisconsin Hospitals and Clinics, the UW-Madison School of Medicine and the University of Wisconsin-Madison.

Dahlberg works closely with the Morgridge Institute scientific team to set the broad research agenda for the institute. In February 2008, the Morgridge Institute appointed stem cell pioneer Dr. James Thomson as the first member of its multidisciplinary leadership team. He serves as director of regenerative biology and a principal scientist. The institute has selected additional scientific leaders for the focus areas including Paul Ahlquist for virology, Thomas Mackie for medical devices, Sangtae "Sang" Kim for pharmaceutical informatics, Miron Livny for core computational technology, Susan Millar for educational research and Rupa Shevde for outreach experiences.

The executive director of the Morgridge Institute works closely with the executive leadership of the Wisconsin Institute of Discovery to develop and evaluate joint efforts in research, education and outreach to the community.

A scientific advisory board comprised of members from the University of Wisconsin-Madison scientific community, as well as researchers from institutions across the country and around the world, will regularly review the broad scientific agenda of the institute to provide an external perspective.

Morgridge Institute Scientific Leaders

Morgridge Scientific Leadership Team

Seated from left:  Sang Kim, James Thomson
Standing from left:  Paul Ahlquist, Susan Millar,
T. Rock Mackie, Miron Livny, Rupa Shevde

“We will focus world-class talent on advancing discoveries in five research challenge areas that have tremendous potential for improving the health of millions of people around the world,” said Sangtae “Sang” Kim, founding executive director of the nonprofit interdisciplinary institute.  “Our mission is to accelerate the ability to treat, cure or eradicate such devastating diseases as hepatitis C, cancer, diabetes and heart disease.”
Download high-resolution photos >